El Nile Company for Pharmaceuticals and Chemical Industries SAE EGX:NIPH:
NILE PHARMACEUTICALS H1 NET PROFIT AFTER TAX EGP 170.1 MILLION
NILE PHARMACEUTICALS H1 REVENUE EGP 1.28 BILLION
Nile Pharmaceuticals H1 Profit EGP 170.1 Mln
Earlier from El-nile Co. For Pharmaceuticals & Chemical Industries
- Nile Pharmaceuticals Board Elects Mohamed Abdel Aal El Sayed As Chairman
- Nile Pharmaceuticals Q1 Profit EGP 106.5 Mln
- Nile Pharmaceuticals Shareholders Approve FY Dividend EGP 2 Per Share